88 related articles for article (PubMed ID: 26334045)
21. The paracrine role of Tie-2-expressing monocytes in tumor angiogenesis.
Ribatti D
Stem Cells Dev; 2009 Jun; 18(5):703-6. PubMed ID: 19186995
[TBL] [Abstract][Full Text] [Related]
22. A Designed Angiopoietin-1 Variant, Dimeric CMP-Ang1 Activates Tie2 and Stimulates Angiogenesis and Vascular Stabilization in N-glycan Dependent Manner.
Oh N; Kim K; Kim SJ; Park I; Lee JE; Seo YS; An HJ; Kim HM; Koh GY
Sci Rep; 2015 Oct; 5():15291. PubMed ID: 26478188
[TBL] [Abstract][Full Text] [Related]
23. Tie2-dependent deletion of α6 integrin subunit in mice reduces tumor growth and angiogenesis.
Bouvard C; Segaoula Z; De Arcangelis A; Galy-Fauroux I; Mauge L; Fischer AM; Georges-Labouesse E; Helley D
Int J Oncol; 2014 Nov; 45(5):2058-64. PubMed ID: 25176420
[TBL] [Abstract][Full Text] [Related]
24. Isoxanthohumol modulates angiogenesis and inflammation via vascular endothelial growth factor receptor, tumor necrosis factor alpha and nuclear factor kappa B pathways.
Negrão R; Duarte D; Costa R; Soares R
Biofactors; 2013; 39(6):608-22. PubMed ID: 23904052
[TBL] [Abstract][Full Text] [Related]
25. Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1 alpha levels in gliomas.
Lee OH; Xu J; Fueyo J; Alonso MM; Liu D; Martin V; Jiang H; Piao Y; Liu TJ; Gomez-Manzano C
Oncogene; 2008 Feb; 27(9):1310-4. PubMed ID: 17704802
[TBL] [Abstract][Full Text] [Related]
26. Lignans from the stems and leaves of Brandisia hancei and their effects on VEGF-induced vascular permeability and migration of HRECs and DLAV formation in zebrafish.
Lee IS; Kim YS; Jung SH; Yu SY; Kim JH; Sun H; Kim JS
Biosci Biotechnol Biochem; 2015; 79(4):581-6. PubMed ID: 25495132
[TBL] [Abstract][Full Text] [Related]
27. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.
Matsubara T; Kanto T; Kuroda S; Yoshio S; Higashitani K; Kakita N; Miyazaki M; Sakakibara M; Hiramatsu N; Kasahara A; Tomimaru Y; Tomokuni A; Nagano H; Hayashi N; Takehara T
Hepatology; 2013 Apr; 57(4):1416-25. PubMed ID: 22815256
[TBL] [Abstract][Full Text] [Related]
28. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage.
Roviezzo F; Tsigkos S; Kotanidou A; Bucci M; Brancaleone V; Cirino G; Papapetropoulos A
J Pharmacol Exp Ther; 2005 Aug; 314(2):738-44. PubMed ID: 15870388
[TBL] [Abstract][Full Text] [Related]
29. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors.
Wyckoff JB; Wang Y; Lin EY; Li JF; Goswami S; Stanley ER; Segall JE; Pollard JW; Condeelis J
Cancer Res; 2007 Mar; 67(6):2649-56. PubMed ID: 17363585
[TBL] [Abstract][Full Text] [Related]
30. Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function.
Minhas N; Xue M; Fukudome K; Jackson CJ
FASEB J; 2010 Mar; 24(3):873-81. PubMed ID: 19858095
[TBL] [Abstract][Full Text] [Related]
31. VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells.
Ourradi K; Blythe T; Jarrett C; Barratt SL; Welsh GI; Millar AB
Respir Res; 2017 Jun; 18(1):116. PubMed ID: 28578669
[TBL] [Abstract][Full Text] [Related]
32. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis.
Fukuhara S; Sako K; Noda K; Zhang J; Minami M; Mochizuki N
Histol Histopathol; 2010 Mar; 25(3):387-96. PubMed ID: 20054809
[TBL] [Abstract][Full Text] [Related]
33. Multitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer model.
Nakazawa Y; Kawano S; Matsui J; Funahashi Y; Tohyama O; Muto H; Nakagawa T; Matsushima T
Cancer Sci; 2015 Feb; 106(2):201-7. PubMed ID: 25458359
[TBL] [Abstract][Full Text] [Related]
34. Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems.
Eklund L; Kangas J; Saharinen P
Clin Sci (Lond); 2017 Jan; 131(1):87-103. PubMed ID: 27941161
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional optical imaging of angiogenesis in animal models.
Roberts RL; Lin PC
Methods Enzymol; 2004; 386():105-22. PubMed ID: 15120248
[No Abstract] [Full Text] [Related]
36. Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy.
Shlamkovich T; Aharon L; Barton WA; Papo N
Oncotarget; 2017 May; 8(20):33571-33585. PubMed ID: 28422724
[TBL] [Abstract][Full Text] [Related]
37. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
38. Tie2: a journey from normal angiogenesis to cancer and beyond.
Martin V; Liu D; Fueyo J; Gomez-Manzano C
Histol Histopathol; 2008 Jun; 23(6):773-80. PubMed ID: 18366015
[TBL] [Abstract][Full Text] [Related]
39. Angiopoietins in angiogenesis.
Fagiani E; Christofori G
Cancer Lett; 2013 Jan; 328(1):18-26. PubMed ID: 22922303
[TBL] [Abstract][Full Text] [Related]
40. You can teach an old dog new tricks: angiopoietin-1 instructs Tie2(pos) myeloid cells to promote neovascularization in ischemic limbs.
Emanueli C; Kränkel N
EMBO Mol Med; 2013 Jun; 5(6):802-4. PubMed ID: 23737442
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
